Heart Failure Research

Heart failure, also known as congestive heart failure or CHF, is an inability of the heart to pump sufficient blood around the body.Heart failure typically occurs secondary to an existing pathology that alters cardiac function. Examples of syndromes that can precede heart failure include myocardial infarction, arrhythmia or infection. These can also cause dilated cardiomyopathy, a condition which accounts for approximately one third of all cases of heart failure. The pathogenesis of heart failure is cyclical and progressive; endogenous mechanisms, which are activated during heart failure in an attempt to counteract the symptoms, actually worsen cardiac function. Cardiac dysfunction, either systolic or diastolic, triggers a decrease in stroke volume and a resultant increase in cardiac output. In healthy individuals the body responds to decreases in cardiac output by initiating the renin-angiotensin-aldosterone system (RAAS) to promote fluid retention, and also by activating the sympathetic nervous system to cause peripheral vasoconstriction. Under normal circumstances this counteracts the imbalance in stroke volume, restoring cardiac output to normal levels. In patients with heart failure the increase in blood volume, together with the heightened peripheral resistance and elevated levels of circulating catecholamines, causes an increased load on the already weakened ventricles with each contraction, and the stroke volume does not return to normal levels. Repeated cycles of this process further weaken the ventricle walls, prompting ventricular hypertrophy and a decreased force of contraction.

Heart Failure Research Products Targets

Products for Heart Failure Research - Page 8

  1. Cat.No. Product Name Information/Activity
  2. BCC2349 Spinorphin Enkephalin-degrading and ACE inhibitor Spinorphin chemical structure
  3. BCC1004 Angiotensin I (human, mouse, rat) Angiotensin 1 (Human) is the precursor to the vasoconstrictor peptide angiotensin II, cleaved by the angiotensin-converting enzyme (ACE). Angiotensin I (human, mouse, rat) chemical structure
  4. BCC5807 Hemopressin (rat) 568588-77-2 Hemopressin (rat) chemical structure
  5. BCC5018 Aliskiren Hemifumarate Aliskiren hemifumarate(CGP 60536 hemifumarate) is a direct renin inhibitor with IC50 of 1.5 nM. Aliskiren Hemifumarate chemical structure
  6. BCN2203 Corticosterone Corticosterone is an adrenocortical steroid that has modest but significant activities as a mineralocorticoid and a glucocorticoid. Corticosterone chemical structure
  7. BCC4395 Benidipine HCl Benidipine hydrochloride is a dihydropyridine calcium channel blocker for the treatment of high blood pressure (hypertension). Benidipine HCl chemical structure
  8. BCC7626 Canrenone Canrenone (Aldadiene; SC9376; SC14266) is an aldosterone antagonist extensively used as a diuretic agent. Canrenone chemical structure
  9. BCC3776 Epleremone Eplerenone is an aldosterone antagonist with an IC50 of 0.36 μM. Epleremone chemical structure
  10. BCC7531 RU 26752 76676-33-0 RU 26752 chemical structure
  11. BCC7146 RU 28318, potassium salt 76676-34-1 RU 28318, potassium salt chemical structure

Items 71 to 80 of 148 total